-
Signature
-
/s/ John O. Faurescu, attorney-in-fact for Dr. Wierenga
-
Issuer symbol
-
CYTK
-
Transactions as of
-
21 Apr 2025
-
Net transactions value
-
-$645,000
-
Form type
-
4
-
Filing time
-
21 Apr 2025, 17:42:08 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CYTK |
Common Stock |
Options Exercise |
$124,200 |
+20,000 |
+80% |
$6.21 |
44,848 |
21 Apr 2025 |
Direct |
|
| transaction |
CYTK |
Common Stock |
Sale |
$769,200 |
-20,000 |
-45% |
$38.46 |
24,848 |
21 Apr 2025 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CYTK |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-20,000 |
-100% |
$0.000000 |
0 |
21 Apr 2025 |
Common Stock |
20,000 |
$6.21 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: